Peer Review reports
From: Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner
Original Submission | ||
---|---|---|
13 Apr 2023 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
11 Jul 2023 | Reviewed | Reviewer Report - Karthik Balakrishnan |
17 Jul 2023 | Reviewed | Reviewer Report - Appadurai Muthamil Iniyan |
18 Jul 2023 | Reviewed | Reviewer Report |
9 Aug 2023 | Author responded | Author comments - Shanshan Sun |
Resubmission - Version 3 | ||
9 Aug 2023 | Submitted | Manuscript version 3 |
17 Aug 2023 | Author responded | Author comments - Shanshan Sun |
Resubmission - Version 4 | ||
17 Aug 2023 | Submitted | Manuscript version 4 |
20 Aug 2023 | Author responded | Author comments - Shanshan Sun |
Resubmission - Version 5 | ||
20 Aug 2023 | Submitted | Manuscript version 5 |
14 Sep 2023 | Reviewed | Reviewer Report - Karthik Balakrishnan |
Resubmission - Version 6 | ||
Submitted | Manuscript version 6 | |
Publishing | ||
26 Sep 2023 | Editorially accepted | |
6 Oct 2023 | Article published | 10.1186/s12885-023-11450-9 |
You can find further information about peer review here.